AI Tools Hub
Ri logo

Rimo

4.4

Rimo is a Japanese-first meeting AI that joins Zoom, Teams, Google Meet and Webex, transcribes and summarises automatically. It sits a tier above the entry-level tools: no free plan, aimed at companies standardising on one tool rather than at individuals trying one.

  • Commercial use OK
  • Japanese UI
  • Enterprise contract
Screenshot of the Rimo website
Pricing
¥4,950/mo
Free tier
No
Commercial use
Permitted
Japanese UI
Yes
Enterprise contract
Available

What it is good for

  • Japanese companies standardising meeting notes across teams
  • Automatic joining and recording without a manual step
  • Organisations that need a Japanese vendor and contract
  • Meetings where the summary matters more than the raw transcript

Strengths and trade-offs

Strengths

  • Joins the major conferencing platforms automatically
  • Japanese summarisation tuned for business meetings
  • Japanese corporate contracting and support
  • Consistent output across a whole organisation

Trade-offs

  • No free tier, so evaluation needs budget
  • Priced per seat above the entry-level alternatives
  • Little advantage for English-language meetings

Editors' review

Japanese meeting AI for organisations rather than individuals

Rimo's positioning is organisational. Automatic joining across Zoom, Teams, Meet and Webex means notes get produced whether or not anyone remembered to start a recording, which is what makes meeting AI stick across a company.

Summarisation is the part tuned for Japanese business meetings — decisions, owners, next steps — rather than a generic abstract, and that is where the time is saved.

The absence of a free tier makes it a decision rather than an experiment, and the per-seat price assumes the whole team is on it. For an individual or a small team, Notta is the cheaper way to find out whether this class of tool helps.

Verdict

A reasonable standard for a Japanese company. Prove the value on a cheaper tool first.

Compiled from official documentation and public sources, with our own editorial judgement. We do not publish figures we cannot source.

Keep looking